Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer
Allison W. Kurian(Stanford University), Steven J. Katz(University of Michigan), Kevin C. Ward(Emory University), Reshma Jagsi(Emory University), Monica Morrow(Memorial Sloan Kettering Cancer Center), Ann S. Hamilton(University of Southern California), Yun Li(University of Michigan), M. Chandler McLeod(VA Center for Clinical Management Research), Sarah T. Hawley(VA Ann Arbor Healthcare System)
Cited by 265
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
|Nature Genetics|2009|1.4k
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
The “Gender Gap” in Authorship of Academic Medical Literature — A 35-Year Perspective
|New England Journal of Medicine|2006|873